Back to Search
Start Over
Lincosamide monotherapy treatment of methicillin-resistant Staphylococcus aureus pneumonia in tropical Australia: a case series.
- Source :
-
European Journal of Clinical Microbiology & Infectious Diseases . Jun2024, Vol. 43 Issue 6, p1247-1250. 4p. - Publication Year :
- 2024
-
Abstract
- Existing recommended first-line antibiotic agents for MRSA pneumonia have several shortcomings. We reviewed 29 cases of community- and hospital-acquired MRSA pneumonia managed at our hospital. Lincosamide monotherapy was administered to 21/29 (72%) and was the predominant antibiotic regimen (> 50% course duration) in 19/29 (66%). Patients receiving lincosamide-predominant monotherapy were no more likely to die or require intensive care unit admission than patients receiving vancomycin-predominant monotherapy (5/19 (26%) versus 4/7 (57%), p = 0.19); 5/7 (71%) patients admitted to ICU and 4/5 (80%) bacteraemic patients received lincosamide-predominant monotherapy. MRSA pneumonia can be safely treated with lincosamide monotherapy if the isolate is susceptible. [ABSTRACT FROM AUTHOR]
- Subjects :
- *METHICILLIN-resistant staphylococcus aureus
*PNEUMONIA
*INTENSIVE care units
Subjects
Details
- Language :
- English
- ISSN :
- 09349723
- Volume :
- 43
- Issue :
- 6
- Database :
- Academic Search Index
- Journal :
- European Journal of Clinical Microbiology & Infectious Diseases
- Publication Type :
- Academic Journal
- Accession number :
- 177898239
- Full Text :
- https://doi.org/10.1007/s10096-024-04816-9